NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment

Sponsor: University of Delaware
Collaborator: National Institute on Aging (NIA)

Purpose

Provides insight into whether NR reduces arterial stiffness, improves arterial function within the brain and restores brain function and memory in patients with “amnestic” mild cognitive impairment. This project has the potential to identify a novel, safe and cost-effective strategy for decreasing age-related memory loss.

Study Design

Double blind, parallel assignment

Dose

500mg 2x daily

Length of Intervention

12 weeks

Intrinsic Capacity

Cognition

Status

Recruiting

Condition or Disease 

Mild Cognitive Impairment

Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.

Clinical Studies, Cognition, RecruitingANAD Staff